News on research and diagnostics in autoimmune disorders including rheumatoid arthritis, lupus, multiple sclerosis, and more.
Euroimmun Nabs CE Mark for Indirect Immunofluorescence Test Instrument
The firm said it is launching sales in countries that accept CE marking of its Uniqo 160 automated indirect immunofluorescence test instrument.
Speciality Dx Firm Sebia Acquires Zeus Scientific
Zeus develops and manufactures in vitro diagnostic immunoassays and related products for infectious and autoimmune diseases.
The CDPath prognostic tool gives Crohn's patients risk scores for serious complications within three years, so they can make more informed treatment decisions.
DxTerity Gets New York State Authorization for Systemic Lupus Erythematosus Test
The test is used to identify patients less likely to respond to standard treatment and more likely to develop a severe kidney disorder.
NIMA Partners, EmpowerDx Collaborate on Celiac Gene Test
The assay from EmpowerDx uses self-collected oral swabs to identify genetic risk for the autoimmune disease, and the companies offer results within 10 business days.